Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme

International Journal of Oncology

Volumn 12, Issue 4, 1998, Pages 905-910

  Fults, Dan ^a   Pedone, Carolyn A ^a   Thompson, Gregory E ^a   Uchiyama, Christopher M ^a   Gumpper, Kathryn L ^b   Iliev, Diana ^b   Vinson, Vickie L ^b   Tavtigian, Sean V ^b   Perry III, William L ^b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b Utah   (United States)

Author keywords

FAS; Glioblastoma; Loss of heterozygosity; MMAC1; MXI1; PTEN; Tumor suppressor gene

Indexed keywords

MICROSATELLITE DNA; PHOSPHOPROTEIN PHOSPHATASE;

ARTICLE; BRAIN TUMOR; CHROMOSOME 10Q; CLINICAL ARTICLE; GENE DELETION; GENE MAPPING; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD95; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031892776     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.4.905     Document Type: Article

References (35)

1. Steck PA, Pershouse MA, Jassr SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF and Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
2. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
3. Li DM and Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor ß. Cancer Res 57: 2124-2129, 1997.
4. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657-3659, 1997.
5. Guldberg P, Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663, 1997.
6. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R and Ellenson LH: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940, 1997.
7. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD and Bigner SH: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187-4190, 1997.
8. Wang SI, Pue J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183-4186, 1997.
9. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64-67, 1997.
10. Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ and Eng C: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16: 333-334, 1997.
11. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R and Tonks NK: P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052-9057, 1997.
12. Rasheed BKA, Fuller GN, Friedman AH, Bigner DD and Bigner SH: Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer 5: 75-82, 1992.
13. Ransom DT, Ritland SR, Moertel CA, Dahl RJ, O'Fallon JR, Scheithauer BW, Kimmel DW, Kelly PJ, Olopade OI, Diaz MO and Jenkins RB: Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer 5: 357-374, 1992.
14. Fults D and Pedone C: Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes Cancer 7: 173-177, 1993.
15. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bemardi G, Lathrop M and Weissenbach J: The 1993-94 Genethon human genetic linkage map. Nat Genet 7: 246-339, 1994.
16. Murray JC, Buetow KH, Weber JL, Ludwigsen S, Scherpbier-Heddema T, Manion F, Quillen J, Sheffield VC, Sunden S, Duyk GM, Weissenbach J, Gyapay G, Dib C, Morrissette J, Lathrop GM, Vignal A, White R, Matsunami N, Gerken S, Melis R, Albertsen H, Plaetke R, Odelberg S, Ward D, Dausset J, Cohen D and Cann H: A comprehensive human linkage map with centimorgan density. Science 265: 2049-2054, 1994.
17. Rasheed BKA, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD and Bigner SH: Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10: 2243-2245, 1995.
18. Albarosa R, Colombo BM, Roz L, Magnani I, Polio B, Cirenei N, Giani C, Conti AMF, diDonato S and Finocchiaro G: Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am. J Hum Genet 58: 1260-1267, 1996.
19. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A and Poustka A: DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumors. Nat Genet 17: 32-39, 1997.
20. Kleihues P, Burger PC and Scheithauer BW: Histological typing of tumours of the central nervous system. 2nd edition. Berlin Springer-Verlag, 1993.
21. Teng DHF, Hu R, Lin H, Davis T, Iliev D, Fryc C, Swedlund B Hansen KL, Vinson VL, Gumper KL, Ellis L, El-Naggar A, Frazier M, Jaser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WAK, Fujii G, Berson A, Bookstein R, Bolen JB, Tavtigian SV and Steck PA: PTEN/MMAC1 mutations in primary tumor specimens and tumor cell lines. Cancer Res 57: 5221-5225, 1997.
22. Cheng J, Liu C, Koopman WJ and Mountz JD: Characterization of the human FAS gene - exon/intron organization and promoter region. J Immunol 154: 1239-1245, 1995.
23. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW and Stone EM: The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16: 325-332, 1993.
24. Wechsler DS, Shelly CA and Dang CV: Genomic organization of human MXI1, a putative tumor suppressor gene. Genomics 32: 466-470, 1996.
25. Ayer DE, Lawrence QA and Eisenman RN: Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80: 767-776, 1995.
26. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI and dePinho RA: An amino-terminal domain of Mxil mediates anti-myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80: 777-786, 1995.
27. Orita M, Suzuki Y, Seikya T and Hayashi K: Rapid and sensitive detection of point mutations and:DNA polmorphisms using the polymerase chain reaction. Genomics 5: 874-879, 1989.
28. Nagata S and Golstein P: The Fas death factor. Science 267: 1449-1455, 1995.
29. Tachibana O, Nakazawa H, Lampe J, Watanabe K, Kleihues P and Ohgaki H: Expression of Fas/APO-1 during the progression of astrocytomas. Cancer Res 55: 5528-5530, 1995.
30. Lahoz EG, Xu L, Schreiber-Agus N and dePinho RA: Supression of Myc, but not Ela, transformation activity by Max-associated proteins, Mad and Mxil. Proc Natl Acad Sci USA 91: 5503-5507, 1994.
31. Zervos AS, Gyuris J and Brent R: Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72: 223-232, 1993.
32. Ayer DE, Kretzner L and Eisenman RN: Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72: 211-222, 1993.
33. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB and Prochownik EV: Mutation of the MXI1 gene in prostate cancer. Nat Genet 9: 249-255, 1995.
34. Decker RA, Moore J, Ponder B and Weber JL: Linkage mapping of human chromosome 10 microsatellite polymorphisms. Genomics 12: 604-606, 1992.
35. Fults D, Pedone CA, Zhu XL, Williams BJ, Jones E and Brothman AR: Molecular cytogenetic analysis of a t(7;10) translocation in a human glioblastoma cell line. Cancer Genet Cytogenet 81: 118-124, 1995.